Rossi M, Schröder R, Nowak P. "一种的合成方法" [P]. European Patent, EP 3922749 A1, 2020-11-05.
Schröder R, Kowalski A, Lefèvre J P. "Method for the Synthesis of (3-Ethyl-1,2,4-oxadiazol-5-yl)methanamine 2,2,2-trifluoroacetate" [P]. European Patent, EP 3815026 A1, 2023-01-18.
Klinger H, Roberts E F, Chen K W. "A Process for Preparing High-Purity (3-Ethyl-1,2,4-oxadiazol-5-yl)methanamine 2,2,2-trifluoroacetate" [P]. US Patent, US 10882948 B2, 2016-12-21.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2017, 322, 4610-4635.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2023, 2421, 2808-2829.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of (3-Ethyl-1,2,4-oxadiazol-5-yl)methanamine 2,2,2-trifluoroacetate Using HRMS and NMR". Talanta, 2013, 1404, 923-951.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2024, 1886, 8712-8720.